Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
About this item
Full title
Author / Creator
Publisher
China: Chinese Anti-Cancer Association (CACA), Cancer Biology & Medicine
Journal title
Language
English
Formats
Publication information
Publisher
China: Chinese Anti-Cancer Association (CACA), Cancer Biology & Medicine
Subjects
More information
Scope and Contents
Contents
Melanoma is the deadliest form of skin cancer and has an incidence that is rising faster than any other solid tumor. Metastatic melanoma treatment has considerably progressed in the past five years with the introduction of targeted therapy （BRAF and MEK inhibitors） and immune checkpoint blockade （anti-CTLA4, anti-PD-1, and anti-PD-L1）. However, eac...
Alternative Titles
Full title
Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_be85f27550154440a2ad74280771be08
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_be85f27550154440a2ad74280771be08
Other Identifiers
ISSN
2095-3941
E-ISSN
2095-3941
DOI
10.7497/j.issn.2095-3941.2014.04.002
